TLR4 and Insulin resistance: A study showed that BBR set-back these effects and restrained LPS-induced TLR4/TNF-α activation, leading to increased insulin receptor and insulin receptor substrate-1 expression in the liver and reduce insulin resistance (Liu et al., 2018).